日本多中心研究验证米兰唾液腺细胞病理报告系统
该多中心研究从日本12家大型机构纳入1608例有组织学对照的细针穿刺样本,评估米兰唾液腺细胞病理报告系统(MSRSGC)的效用。各诊断类别风险分层清晰,诊断肿瘤准确率97.8%、诊断恶性准确率97.3%,支持MSRSGC用于风险分层与质量控制。
要点
- MSRSGC各诊断类别的恶性肿瘤风险呈梯度上升,支持其风险分层价值。
- 诊断肿瘤准确率97.8%,诊断恶性准确率97.3%。
- 使用Romanowsky染色制片的机构非诊断率及非肿瘤类别的肿瘤/恶性风险更低。
核心结论
- MSRSGC在日本人群中有助于风险分层和质量控制,广泛使用可提高唾液腺细胞学准确性并改善患者诊疗。
研究设计与样本
- 多中心研究,从日本12家大型机构回顾纳入1608例有组织学诊断对照的细针穿刺样本,前瞻或回顾性归入MSRSGC类别并与组织学诊断比较。
主要发现
- 各类别构成:非诊断性18.1%、非肿瘤性4.1%、意义不明的异型性11.5%、肿瘤-良性43.7%、恶性潜能未定的唾液腺肿瘤9.6%、可疑恶性3.6%、恶性9.4%。
- 肿瘤风险与恶性风险:非诊断性72.9%和13.4%;非肿瘤性15.2%和9.1%;意义不明的异型性77.9%和24.9%;肿瘤-良性99%和1.8%。
- 肿瘤风险与恶性风险:恶性潜能未定的唾液腺肿瘤94.8%和37%;可疑恶性100%和89.7%;恶性100%和99.3%。
- 诊断肿瘤准确率97.8%,诊断恶性准确率97.3%。
- 使用Romanowsky染色制片的机构非诊断率更低,非肿瘤性类别的肿瘤风险和恶性风险也更低。
临床怎么用
- 可依据MSRSGC各类别的肿瘤风险与恶性风险对唾液腺细针穿刺样本进行分层报告与临床沟通。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) is a risk-stratification reporting system that was introduced in 2018. The objective of this multi-institutional study was to evaluate the utility of the MSRSGC in Japan. METHODS: In total, 1608 fine-needle aspiration samples with matching histologic diagnoses were retrieved from 12 large institutions in Japan. The diagnostic categories of the MSRSGC were assigned prospectively or retrospectively, and the results were compared with the histologic diagnoses. RESULTS: The cases were classified as follows: nondiagnostic, 18.1%; non-neoplastic, 4.1%; atypia of undetermined significance, 11.5%; neoplasm-benign, 43.7%; salivary gland neoplasm of uncertain malignant potential, 9.6%; suspicious for malignancy, 3.6%; and malignant, 9.4%. The risk of neoplasm and the risk of malignancy in each MSRSGC category were as follows: nondiagnostic, 72.9% and 13.4%, respectively; non-neoplastic, 15.2% and 9.1%, respectively; atypia of undetermined significance, 77.9% and 24.9%, respectively; neoplasm-benign, 99% and 1.8%, respectively; salivary gland neoplasm of uncertain malignant potential, 94.8% and 37%, respectively; suspicious for malignancy, 100% and 89.7%, respectively; and malignant, 100% and 99.3%, respectively. The accuracy of the MSRSGC for diagnosing neoplasms was 97.8%, and its accuracy for diagnosing malignancy was 97.3%. Institutions that used Romanowsky-stained preparations had lower nondiagnostic rates and lower risks of neoplasm and malignancy in the non-neoplastic category. CONCLUSIONS: The MSRSGC is useful for risk stratification and quality control. Widespread use of the MSRSGC would improve the accuracy of salivary gland cytology and lead to better patient care in Japan.
引用
- Higuchi K, Urano M, Akiba J, et al. A multi-institutional study of salivary gland cytopathology: Application of the Milan System for Reporting Salivary Gland Cytopathology in Japan. Cancer Cytopathol. 2021. PMID: 34478237. doi:10.1002/cncy.22505
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。